LeMaitre Operating Margin from 2010 to 2024
| LMAT Stock | USD 107.97 2.10 1.98% |
Check LeMaitre Vascular financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among LeMaitre Vascular's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Total Revenue of 203.2 M or Gross Profit of 133.4 M, as well as many indicators such as Price To Sales Ratio of 6.84, Dividend Yield of 0.0125 or PTB Ratio of 4.64. LeMaitre financial statements analysis is a perfect complement when working with LeMaitre Vascular Valuation or Volatility modules.
LeMaitre | Operating Margin |
Latest LeMaitre Vascular's Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of LeMaitre Vascular over the last few years. It is LeMaitre Vascular's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in LeMaitre Vascular's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 0.24 % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
LeMaitre Operating Margin Regression Statistics
| Arithmetic Mean | 0.14 | |
| Coefficient Of Variation | 52.96 | |
| Mean Deviation | 0.06 | |
| Median | 0.15 | |
| Standard Deviation | 0.07 | |
| Sample Variance | 0.01 | |
| Range | 0.2897 | |
| R-Value | 0.71 | |
| Mean Square Error | 0 | |
| R-Squared | 0.51 | |
| Significance | 0 | |
| Slope | 0.01 | |
| Total Sum of Squares | 0.07 |
LeMaitre Operating Margin History
About LeMaitre Vascular Financial Statements
LeMaitre Vascular shareholders use historical fundamental indicators, such as Operating Margin, to determine how well the company is positioned to perform in the future. Although LeMaitre Vascular investors may analyze each financial statement separately, they are all interrelated. The changes in LeMaitre Vascular's assets and liabilities, for example, are also reflected in the revenues and expenses on on LeMaitre Vascular's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts. Lemaitre Vascular operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 450 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for LeMaitre Stock Analysis
When running LeMaitre Vascular's price analysis, check to measure LeMaitre Vascular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LeMaitre Vascular is operating at the current time. Most of LeMaitre Vascular's value examination focuses on studying past and present price action to predict the probability of LeMaitre Vascular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LeMaitre Vascular's price. Additionally, you may evaluate how the addition of LeMaitre Vascular to your portfolios can decrease your overall portfolio volatility.